Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy ...

The US Food and Drug Administration (FDA) has approved Deciphera Pharmaceuticals’ Romvimza (vimseltinib) to treat adults with ...

A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...

Baxter International has appointed Brent Shafer, who has been serving as the company’s Lead Independent Director, as Chair ...

NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

Baxter International has appointed Heather Knight, who has been leading the company’s Medical Products and Therapies unit, as Executive Vice President and Chief Operating Officer (COO).

Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the first once-monthly treatment targeting factor XIIa to prevent hereditary ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the Marketing Authorization Application for its prostate cancer PET imaging ...